Evidence map›Paper›PMID 38732354›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Inferior Frontal Sulcal Hyperintensities on Brain MRI Are Associated with Amyloid Positivity beyond Age-Results from the Multicentre Observational DELCODE Study.

Marc Dörner, Katharina Seebach, Michael T Heneka, Inga Menze, Roland von Känel, Sebastian Euler, Frank Schreiber, Philipp Arndt, Katja Neumann, Annkatrin Hildebrand and 50 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Observational
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

60 authors.

Marc DörnerGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.ORCID 0000-0003-3229-1677
Katharina SeebachGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.
Michael T HenekaLuxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 4367 Belvaux, Luxembourg.
Inga MenzeGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.
Roland von KänelDepartment of Consultation-Liaison-Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-8929-5129
Sebastian EulerDepartment of Consultation-Liaison-Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
Frank SchreiberGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.ORCID 0000-0002-9484-8613
Philipp ArndtGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.
Katja NeumannDepartment of Neurology, Otto-von-Guericke University, 39120 Magdeburg, Germany.
Annkatrin HildebrandDepartment of Neurology, Otto-von-Guericke University, 39120 Magdeburg, Germany.
Anna-Charlotte JohnDepartment of Neurology, Otto-von-Guericke University, 39120 Magdeburg, Germany.
Anthony TyndallDepartment of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
Johannes KirchebnerDepartment of Forensic Psychiatry, University Hospital of Psychiatry Zurich, University of Zurich, 8032 Zurich, Switzerland.
Pawel TacikDepartment of Parkinson's Disease, Sleep and Movement Disorders, University Hospital Bonn, 53127 Bonn, Germany.
Robin JansenDepartment of Neurology, Heinrich Heine University, 40225 Düsseldorf, Germany.
Alexander GrimmCenter for Neurology, Tuebingen University Hospital and Hertie-Institute for Clinical Brain Research, Eberhard Karls University Tuebingen, 72076 Tuebingen, Germany.
Solveig HenneickeGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.ORCID 0000-0002-9103-7276
Valentina PerosaJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA 02114, USA.ORCID 0000-0002-3551-5237
Sven G MeuthDepartment of Neurology, Heinrich Heine University, 40225 Düsseldorf, Germany.ORCID 0000-0003-2571-3501
Oliver PetersGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 10117 Berlin, Germany.
Julian Hellmann-RegenGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 10117 Berlin, Germany.
Lukas PreisInstitute of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 14129 Berlin, Germany.
Josef PrillerGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 10117 Berlin, Germany.
Eike Jakob SpruthGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 10117 Berlin, Germany.
Anja SchneiderGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 53127 Bonn, Germany.
Klaus FliessbachGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 53127 Bonn, Germany.
Jens WiltfangGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 37075 Goettingen, Germany.
Frank JessenGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 53127 Bonn, Germany.
Ayda RostamzadehDepartment of Psychiatry, Medical Faculty, University of Cologne, 50924 Cologne, Germany.
Wenzel GlanzGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.ORCID 0000-0002-5865-4176
Jan Ben SchulzeDepartment of Consultation-Liaison-Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
Sarah Lavinia Florence SchieblerDepartment of Consultation-Liaison-Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.ORCID 0009-0000-8112-546X
Katharina BuergerGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 81377 Munich, Germany.
Daniel JanowitzInstitute of Stroke and Dementia Research (ISD), University Hospital, LMU Munich, 81377 Munich, Germany.
Robert PerneczkyGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 81377 Munich, Germany.
Boris-Stephan RauchmannDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, 81377 Munich, Germany.ORCID 0000-0003-4547-6240
Stefan TeipelGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 18147 Rostock, Germany.
Ingo KilimannGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 18147 Rostock, Germany.
Christoph LaskeGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 72076 Tuebingen, Germany.
Matthias H MunkGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 72076 Tuebingen, Germany.
Annika SpottkeGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 53127 Bonn, Germany.
Nina Roy-KluthGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 53127 Bonn, Germany.
Michael WagnerGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 53127 Bonn, Germany.ORCID 0000-0003-2589-6440
Ingo FrommannGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 53127 Bonn, Germany.ORCID 0000-0002-7244-2014
Falk LüsebrinkGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.
Peter DechentMR-Research in Neurosciences, Department of Cognitive Neurology, Georg-August-University Goettingen, 37073 Gottingen, Germany.
Stefan HetzerBerlin Center for Advanced Neuroimaging, Charité-Universitätsmedizin Berlin, 14129 Berlin, Germany.
Klaus SchefflerDepartment for Biomedical Magnetic Resonance, University of Tuebingen, 72076 Tuebingen, Germany.
Luca KleineidamGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 53127 Bonn, Germany.
Melina StarkGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 53127 Bonn, Germany.
Matthias SchmidGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 53127 Bonn, Germany.
Ersin ErsözlüGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 10117 Berlin, Germany.ORCID 0000-0001-6503-5894
Frederic BrosseronGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 53127 Bonn, Germany.
Michael EwersGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 81377 Munich, Germany.
Björn H SchottGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 37075 Goettingen, Germany.ORCID 0000-0002-8237-4481
Emrah DüzelGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.
Gabriel ZieglerGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.
Hendrik MatternGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.
Stefanie SchreiberGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.ORCID 0000-0003-4439-4374
Jose BernalGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.ORCID 0000-0003-3167-5134

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inferior frontal sulcal hyperintensities (IFSHs) on fluid-attenuated inversion recovery (FLAIR) sequences have been proposed to be indicative of glymphatic dysfunction. Replication studies in large and diverse samples are nonetheless needed to confirm them as an imaging biomarker. We investigated whether IFSHs were tied to Alzheimer's disease (AD) pathology and cognitive performance. We used data from 361 participants along the AD continuum, who were enrolled in the multicentre DELCODE study. The IFSHs were rated visually based on FLAIR magnetic resonance imaging. We performed ordinal regression to examine the relationship between the IFSHs and cerebrospinal fluid-derived amyloid positivity and tau positivity (Aβ42/40 ratio ≤ 0.08; pTau181 ≥ 73.65 pg/mL) and linear regression to examine the relationship between cognitive performance (i.e., Mini-Mental State Examination and global cognitive and domain-specific performance) and the IFSHs. We controlled the models for age, sex, years of education, and history of hypertension. The IFSH scores were higher in those participants with amyloid positivity (OR: 1.95, 95% CI: 1.05-3.59) but not tau positivity (OR: 1.12, 95% CI: 0.57-2.18). The IFSH scores were higher in older participants (OR: 1.05, 95% CI: 1.00-1.10) and lower in males compared to females (OR: 0.44, 95% CI: 0.26-0.76). We did not find sufficient evidence linking the IFSH scores with cognitive performance after correcting for demographics and AD biomarker positivity. IFSHs may reflect the aberrant accumulation of amyloid β beyond age.

Indexed as

Alzheimer’s diseaseamyloid positivityfluid-attenuated inversion recoveryglymphatic systeminferior frontal sulcal hyperintensitymagnetic resonance imaging

Identifiers

PMID38732354
PMCPMC11083612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.